← back to search

Parin Shah

Columbia University Irving Medical Center · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Single-cell and spatial transcriptomics, and Cancer Genomics and Diagnostics.
h-index
18
citations
9,305
works
48
NIH funding
primary concept
Medicine
email

Recent publications

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
Nature Medicine 2025cited by 48position: middledoi
Micronuclear collapse from oxidative damage
Science 2024cited by 66position: middledoi
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Cancer Cell 2023cited by 92position: middledoi
Transcriptional mediators of treatment resistance in lethal prostate cancer
Nature Medicine 2021cited by 191position: middledoi
A single-cell landscape of high-grade serous ovarian cancer
Nature Medicine 2020cited by 518position: middledoi
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Cell 2018cited by 1,430position: middledoi
Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes
eLife 2018cited by 738position: middledoi
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Cancer Discovery 2017cited by 574position: middledoi
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Science 2016cited by 5,167position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shu Wang · Nanjing Medical University1 papers (2018–2018)Clarence Yapp · Harvard University1 papers (2018–2018)Benjamin Izar · Columbia University Irving Medical Center1 papers (2018–2018)Jia‐Ren Lin · Harvard University1 papers (2018–2018)Peter K. Sorger · University of Massachusetts Boston1 papers (2018–2018)Sandro Santagata · Harvard University1 papers (2018–2018)Shaolin Mei · Center for Systems Biology1 papers (2018–2018)